Infectious Diseases Society of America: “Monoclonal Antibodies.”
The New England Journal of Medicine: “Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.”
William Fales, MD, medical director, Michigan Department of Health and Human Services, Division of EMS and Trauma.
Lindsay Petty, MD, infectious disease doctor, University of Michigan.
Eli Lilly: “Emergency Use Authorization (EUA) for the Treatment of COVID-19.”
FDA: “Emergency Use Authorization (EUA) for bamlanivimab 700mg IV Center for Drug Evaluation and Research (CDER) Memorandum on Fact Sheet Update.”
David Wohl, MD, infectious disease expert, University of North Carolina.
CDC: “People with Certain Medical Conditions.”
Regeneron: “REGEN-COV for COVID-19: Emergency Use Authorization (EUA).”